Your browser doesn't support javascript.
loading
Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.
Tang, Jing; Zhang, Shu-Xia; Zhang, Jing; Li, Xi-Yan; Zhou, Jian-Fang; Zou, Shu-Mei; Bo, Hong; Xin, Li; Yang, Lei; Liu, Jia; Huang, Wei-Juan; Dong, Jie; Wang, Da-Yan.
  • Tang J; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Zhang SX; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Zhang J; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Li XY; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Zhou JF; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Zou SM; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Bo H; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Xin L; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Yang L; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Liu J; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Huang WJ; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Dong J; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China.
  • Wang DY; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Reference and Research on Influenza, Beijing, China. Electronic address: dayanwang@cnic.org.cn.
Virology ; 549: 77-84, 2020 10.
Article en En | MEDLINE | ID: mdl-32853849
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Virales / Virus Reordenados / Farmacorresistencia Viral / Subtipo H7N9 del Virus de la Influenza A / Mutación / Neuraminidasa Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Virales / Virus Reordenados / Farmacorresistencia Viral / Subtipo H7N9 del Virus de la Influenza A / Mutación / Neuraminidasa Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article